SCHEMBL17054150

SCHEMBL17054150

CN(c1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC4=C(c5ccc(Cl)cc5)CC(C)(C)CC4)CC3)cc2Oc2ccc3[nH]ccc3c2)cc1[N+](=O)[O-])C1CCS(O)(O)C1

nearest known ligand 0.77

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 3/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17054148 0.95 BCL2 (0.75) BCL2
SCHEMBL1958112 0.90 BCL2 (0.88) BCL2
SCHEMBL1957435 0.89 BCL2 (0.87) BCL2
SCHEMBL1957488 0.89 BCL2 (0.76) BCL2
SCHEMBL1960251 0.88 BCL2 (0.85) BCL2
SCHEMBL1957817 0.87 BCL2 (0.91) BCL2
SCHEMBL1955089 0.87 BCL2 (0.87) BCL2
SCHEMBL1956290 0.87 BCL2 (0.87) BCL2
SCHEMBL1958236 0.86 BCL2 (0.88) BCL2
SCHEMBL17054149 0.86 BCL2 (0.73) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9125913-B2 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases ABBVIE INC. (US) 2015-09-08 — — US claimed
Send feedback